| Literature DB >> 32010050 |
Ahmad Marashly1, Jennifer Koop2, Michelle Loman2, Yu-Wen Lee1, Sean M Lew3.
Abstract
Background: Electrical Status Epilepticus in Sleep (ESES) is an epileptic encephalopathy syndrome characterized by infrequent clinical seizures and prominent interictal burden during slow wave sleep associated with cognitive deficits and behavioral dysfunction. Medical treatment with anti-epileptic drugs is often unsuccessful. Resective surgery may be a valuable option in carefully selected patients. This case series aims to describe the indications, long term results and utility of resective surgery for ESES.Entities:
Keywords: cognitive outcome; electrical status epilepticus in sleep; epilepsy surgery; hemispherotomy; seizure outcome
Year: 2020 PMID: 32010050 PMCID: PMC6974623 DOI: 10.3389/fneur.2019.01397
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Presurgical clinical features.
| 1 | Undetermined | 2 years | 3 years | Spastic quadriparesis, L > R | 6 years | Head atonic, daily; Staring/unresponsiveness (hypomotor), daily; Generalized motor, 2/week | Felbamate, levetiracetam, topiramate, clonazepam | Diffuse volume loss, manifestation of prenatal injury, L > R | No |
| 2 | L | 1st day of life | 8 years | R hemiparesis | 12 years | Nocturnal arousals, frequency not specified | Valproic acid, clonazepam | LMCA encephalomalacia | No |
| 3 | L | 3rd day of life | 1 year | None | 3.5 years | Tonic spasms resolved by the age of 1 year. Undefined frequency | Phenobarbital, valproic acid | L hemimegalencephaly | No |
| 4 | L | 3.5 years | 8 years | R hemiparesis, R hemianopsia | 2.5 years | R head version, R arm clonic, every 6–10 weeks; SGTCS, 3 altogether (status) | Valproic acid, topiramate | LMCA encephalomalacia | No |
| 5 | R | 2 years | 10 years | L hemiparesis; L hemianopsia | 10 years | Staring and unresponsiveness, 2–3/week until age 4 years. | Felbamate | RMCA encephalomalacia | No |
| 6 | L | 2 years, 11 months | 10.5 years | R hemiparesis; R hemianopsia | 7.5 years | R face clonic with unresponsiveness; R head version → R arm tonic → SGTS; stopped by 6 years | Valproic acid | L hemispheric volume loss; Sequelae of interventricular hemorrhage in prematurity | No |
| 7 | R | 2 years | 3.5 years | L hemiparesis | 6 years | Non-specific aura → ictal emesis → L versive seizure, infrequent stopped by 3.5 years | Valproic acid, felbamate | Right frontoparietal encephalomalacia; Sequelae of congenital hydrocephalus | Yes, subtotal R frontal lobectomy at 6 years of age |
| 8 | L | 4 years | 6 years | None | 4 years | Nausea → ictal emesis → dialeptic, 1–2/month; Facial flushing → L arm clonic → L head version → SGCTS, unknown frequency | Oxcarbazepine, lacosamide, clorazepate, Ketogenic diet | Unilateral right ventriculomegaly | Yes, R parietal and occipital limited cortical resections |
| 9 | L | N/A | 3 years | R spastic hemiparesis | N/A | No clinical seizures | Clonazepam | LMCA encephalomalacia | No |
| 10 | L | 1 year | 1 year, 4 months | R spastic hemiparesis | 4 months | Hypomotor → R version → bilateral asymmetric clonic sz → R arm clonic sz, with intact consciousness, 3/week | Levetiracetam, oxcarbazepine, clobazam | LMCA encephalomalacia | No |
| 11 | R | 2 years | 8.5 years | L spastic hemiparesis | 8.5 years | Autonomic (pallor, cyanosis) → hypomotor, daily; | Valproic acid, phenytoin, clobazam | R hemispheric malformation of cortical development | No |
| 12 | L | 1st week of life | 7.5 years | R spastic hemiparesis | 8 years | R hemibody clonic sz, 1 every 1–4 weeks; Dialeptic, Daily; Atonic sz, Rare | Felbamate, phenytoin, clobazam | Diffuse L hemispheric encephalomalacia; Sequelae of interventricular hemorrhage | L temporal lobectomy; L parieto-occipital resection |
| 13 | L | 3 years 10 months | 5.5 years | None | 2 years 8 months | R face clonic seizure, daily; R arm clonic sz → SGTCS, rare | Clobazam, lamotrigine, prednisone | Normal | No |
| 14 | L | 2 years | 8 years | None | 7 years | GTCS, frequency not specified. Stopped by age 8 years | Levetiracetam, lamotrigine, zonisamide, clonazepam | Non-specific white matter abnormalities | No |
SGTCS, Secondarily Generalized Tonic Clonic Seizure; LMCA, left middle cerebral artery; RMCA, right middle cerebral artery; UE, upper extremity; LE, lower extremity; R, right; L, left; sz, seizure.
Pre- and post-surgical EEG features.
| 1 | 3 | 100% | 90% | Generalized | No | 5% | 0% | 18 months |
| 2 | 8 | 100% | Unavailable | Focal | Yes | 7% | 0% | 3.5 years |
| 3 | 1 | 100% | 100% | Focal | Yes | 90% | 80% | 7 years |
| 4 | 8 | 99% | 34% | Focal | Yes | 30% | 13% | 32 months |
| 5 | 10 | >85% | Unavailable | Focal | Yes | 0% | 0% | 24 months |
| 6 | 10.5 | 100% | Unavailable | Focal | Yes | 3% | 1% | 4.5 years |
| 7 | 3.5 | 91% | 27% | Focal | Yes | 6% | 6% | 2 years |
| 8 | 6 | 88% | 26% | Focal | Yes | 0% | 0% | 18 months |
| 9 | 3 | 98% | 69% | Focal | Yes | 0% | 0% | 14 months |
| 10 | 1.3 | 82% | 60% | Focal | Yes | 20% | 7% | 18 months |
| 11 | 8.5 | 79% | 3% | Focal | Yes | 20% | 25% | 2.5 years |
| 12 | 7.5 | 100% | 14% | Focal | Yes | 0% | 0% | 9 years |
| 13 | 5.5 | 100% | 94% | Focal | N/A | 84% | 7% | 3 years |
| 14 | 8 | 100% | Unavailable | Focal | N/A | 20% | 0% | 13 months |
R, right; L, left.
Group means of intellectual, adaptive and behavioral data.
| Age at evaluation (years) | 7.56 (2.61) | 3.3–12.3 | 9.11 (2.64) | 6.6–15.4 |
| Intellectual abilities | 67.57 (15.37) | 42.0–96.0 | 61.79 (14.57) | 38.0–87.0 |
| Adaptive skills | 71.72 (14.03) | 39.0–95.0 | 71.11 (12.32) | 40.0–82.0 |
| Attention problems | 70.91 (12.90) | 57–97 | 67.50 (7.29) | 57–83 |
See description of measures used in text.
Individual pre- and post-surgical intellectual, adaptive and behavioral data.
| 1 | Stable | 42 | 39 | – | 5 | 38 | 40 | 83 | Positive |
| 2 | Decline | 53 | 67 | 66 | 54 | – | – | Positive | |
| 3 | Stable | 58 | 67 | 80 | 38 | 50 | – | – | Decline |
| 4 | Decline | 79 | 79 | 62 | 8 | 85 | 77 | 57 | Positive |
| 5 | Stable | 80 | – | 97 | 10 | 80 | – | 66 | Positive |
| 6 | Stable | 45 | 69 | 59 | 46 | 45 | 69 | 66 | Positive |
| 7 | Decline | 75 | 85 | 71 | 28 | 63 | 79 | 71 | Decline |
| 8 | Stable | 73 | 77 | 90 | 4 | 58 | 75 | 73 | Decline |
| 9 | Decline | 72 | 70 | – | 28 | 70 | 73 | 75 | Positive |
| 10 | No Data | 49 | 66 | 62 | 20 | 59 | 70 | 59 | Positive |
| 11 | Decline | 58 | 95 | 69 | 6 | 63 | 82 | 69 | Positive |
| 12 | Decline | 66 | 75 | – | 6 | 51 | 74 | 61 | Decline |
| 13 | Stable | 96 | – | 57 | 7 | 87 | – | 66 | Decline |
| 14 | Stable | 58 | – | 67 | 11 | 62 | – | 64 | Positive |
Stable indicates continued appropriate development. Decline indicates loss of skills or lack of developmental progress. Positive outcome was defined as arrest of decline, gains in performance or stability of function.
Post-surgical outcomes.
| 1 | 6 | R parieto-occipital resection | Yes | Focal cortical dysplasia | 2 | Felbamate, topiramate | None | III | Positive |
| 2 | 12 | L hemispherotomy | No | Gliosis | 3.5 | None | None | I | Positive |
| 3 | 3.5 | L hemispherotomy | No | Focal cortical dysplasia | 7 | None | R hemiparesis | I | Decline |
| 4 | 6 | L hemispherotomy | No | Focal cortical dysplasia | 7.5 | None | None | I | Positive |
| 5 | 12 | R hemispherotomy | No | Focal cortical dysplasia | 3.5 | None | None | I | Positive |
| 6 | 10.5 | L hemispherotomy | No | Hippocampal sclerosis; Focal cortical dysplasia | 4 | None | None | I | Positive |
| 7 | 8 | R hemispherotomy | No | Hippocampal sclerosis | 2 | Valproic acid, for behavioral concerns | None | I | Decline |
| 8 | 8 | R temporo-parieto-occipital disconnection | Yes | Gliosis | 2 | Oxcarbazepine, lacosamide | None | I | Decline |
| 9 | 5 | L hemispherotomy | No | Gliosis | Clonazepam | None | N/A | Positive | |
| 10 | 5.8 | L hemispherotomy | No | Gliosis | 1.5 | Oxcarbazepine | None | I | Positive |
| 11 | 10.5 | R hemispherotomy | No | Focal cortical dysplasia | 2.5 | Clobazam | None | I | Positive |
| 12 | 8 | L hemispherotomy | No | Gliosis | 9 | Valproic acid, felbamate | None | I | Decline |
| 13 | 6.5 | L corticectomy in lateral superior frontal gyrus | Yes | Gliosis | 3.5 | Phenytoin, lamotrigine, clobazam | None | V | Decline |
| 14 | 9 | L frontal lobectomy | Yes | Gliosis | 11 | Lamotrigine | None | III | Positive |
Positive is defined as arrest of decline, gains in performance or stability of function. R, right; L, left.
Figure 1Patient #x. Axial T1-weighted MRI obtained at age 5 years, demonstrating a left middle cerebral artery distribution infarct and a disproportionately small left cerebral hemisphere.
Figure 2Pre-operative EEG showing an ESES pattern occupying 90% of the sleep recording. The interictal discharges localize to the left frontal, and left occipital regions independently. Volume conduction to the right frontal and right occipital regions is also seen, but the maximum clearly lateralizes to the left hemisphere. Display setup: bipolar double banana montage, 10 s page, low frequency filter 1 Hz, high frequency filter 70 Hz, gain 100 microvolts per cm.
Figure 3Post-operative EEG obtained 14 months after left hemispherotomy. There is complete resolution of ESES with no interictal discharges. Only expected non-epileptiform changes of continuous slow and asymmetry of sleep structures in the left hemisphere are seen. Display setup: bipolar double banana montage, 10 s page, low frequency filter 1 Hz, high frequency filter 70 Hz, gain 100 microvolts per cm.